Skip to content

  • INVESTORS
    • PRESENTATION
MY ACCOUNT
SCHEDULE A TEST
CALL 800-522-7424
Psychemedics
  • ABOUT
  • HAIR TESTING
    • The Science Behind Hair Drug Testing
    • Words of Warning
    • 5-Panel Drug Test
      • Amphetamines
      • Cocaine
      • Marijuana
      • Opiates
      • PCP Hair Drug Test
    • Fentanyl Hair Drug Testing
    • Adderall Testing
    • Benzodiazepines Testing
    • Synthetic Cannabinoids
    • Hair Alcohol Testing (EtG)
    • At Home Drug Testing Kit – PDT 90
    • Hair Test FAQs
  • INDUSTRIES
    • Education/School Drug Testing
    • Transportation
    • Services
    • Manufacturing
    • Oil and Gas
    • Law Enforcement
  • WHY PSYCHEMEDICS
  • RESOURCES
    • Blogs
    • White Papers
    • Press Releases
    • For Our Clients
    • Case Studies
    • Representative Cases
  • COLLECTORS
  • CONTACT

Client Newsletter – August 2012 – Special Edition

September 2, 2020August 8, 2012 by Psychemedics

Download the PDF file Client Newsletter - August 2012 - Special Edition.
Categories Corporate, Newsletters, Uncategorized
How Prevalent is Drug Use in the Workplace?
Psychemedics Corporation Announces Record Revenues, Declares 64th Consecutive Quarterly Dividend

Recent Posts

  • Psychemedics Corporation Launches New Ketamine Hair Testing Service
  • Psychemedics Corporation’s Board of Directors Approves Plan to Terminate Registration of Its Common Stock
  • Drugs in the Digital Age: How Online Trends Influence Drug Use
  • The Evolution of Hair Testing: From Historical Roots to Modern Methods
  • Hair Testing vs. Urine Testing: Which is More Reliable?

Categories

  • Blog Posts
  • Corporate
  • Drug News
  • Fentanyl
  • Healthcare
  • News
  • Newsletters
  • Press Releases
  • Schools
  • Uncategorized
  • Webinars
CORPORATE HEADQUARTERS
5220 Spring Valley Road, Ste 230
Dallas, TX 75254
United States
(800) 522-7424

PSYCHEMEDICS

Home

Hair Testing

Industries

Collectors

Call 800-522-7424

© Copyright 2024 – Psychemedics Corporation
This site is governed solely by applicable U.S. laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to the application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice. You should view the Investor Relations section in order to receive the most current information made available by Psychemedics Corporation.

© 2024 Psychemedics • Built with GeneratePress